Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysis.
Research Support, N.I.H., Extramural
Journal:The Lancet. Global health, Volume: 7, Issue: 2
Xpert MTB/RIF, the most widely used automated nucleic acid amplification test for tuberculosis, is available in more than 130 countries. Although diagnostic accuracy is well documented, anticipated improvements in patient outcomes have not been clearly identified. We performed an individual patient data meta-analysis to examine improvements in patient outcomes associated with Xpert MTB/RIF.